IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protalix Biotherapeutics Inc

CUSIP: 74365AAJ0 | 4 institutional holders

Quarters

Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2024

Highbridge Capital Management LLC12,500,000
0.4% of portfolio›$12.9M
Citigroup Inc2,500,000
0.0% of portfolio›$2.6M
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Highbridge Capital Management LLC
12,500,000$12.9M0.4%ValueVery HighNew York, NY2024-08-12
Citigroup Inc
2,500,000$2.6M0.0%CoreMediumNew York, NY2024-08-12
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2024-07-23